Who
Steven J. Schoch
Director
Company insider
Files Form 4 as: Director, Zura Bio; Chief Financial Officer, 23andMe Holding Co; Director, Arena Pharmaceuticals.
In numbers
- Trades disclosed
- 16
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 11 Jun 2021
- Last trade
- 17 Jun 2026
- Last filed
- 22 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Jun 2026filed 22 Jun 2026 | ZURA Zura Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —51,000 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | ZURA Zura Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —51,000 at $0.00 | filing |
| 21 May 2025filed 22 May 2025 | ZURA Zura Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —51,000 at $0.00 | filing |
| 9 Dec 2024filed 11 Dec 2024 | ZURA Zura Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —117,000 at $0.00 | filing |
| 18 May 2023filed 22 May 2023 | ZURA Zura Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —7,652 at $0.00 | filing |
| 20 Aug 2022filed 22 Aug 2022 | 23andMe Holding Co | SEC FORM 4 Code F | $16K4,782 at $3.33 | filing |
| 1 Jun 2022filed 2 Jun 2022 | 23andMe Holding Co | SEC FORM 4 Code F | $13K4,782 at $2.82 | filing |
| 11 Mar 2022filed 11 Mar 2022 | Arena Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —3,601 | filing |
| 11 Mar 2022filed 11 Mar 2022 | Arena Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —7,202 | filing |
| 11 Mar 2022filed 11 Mar 2022 | Arena Pharmaceuticals | SEC FORM 4 Code J | —4,600 | filing |
| 9 Feb 2022filed 11 Feb 2022 | 23andMe Holding Cooption or derivative | SEC FORM 4 Code A | —487,127 at $0.00 | filing |
| 9 Feb 2022filed 11 Feb 2022 | 23andMe Holding Co | SEC FORM 4 Code A | —221,227 at $0.00 | filing |
| 11 Jun 2021filed 15 Jun 2021 | Arena Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —3,601 at $0.00 | filing |
| 11 Jun 2021filed 15 Jun 2021 | Arena Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —7,202 at $0.00 | filing |
| 11 Jun 2021filed 15 Jun 2021 | Arena Pharmaceuticals | SEC FORM 4 Code A | —1,533 at $0.00 | filing |
| 11 Jun 2021filed 15 Jun 2021 | Arena Pharmaceuticals | SEC FORM 4 Code A | —3,067 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.
Related people
Nobody else traded the same names lately.